% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@INBOOK{Herholz:280934,
author = {Herholz, Karl and Teipel, Stefan and Hellwig, Sabine and
Langner, Sönke and Rijntjes, Michel and Klöppel, Stefan
and Weiller, Cornelius and Meyer, Philipp T.},
title = {{F}unctional and {M}olecular {N}euroimaging},
volume = {1},
publisher = {Elsevier},
reportid = {DZNE-2025-01017},
pages = {576 - 600.e10},
year = {2021},
comment = {Bradley and Daroff's Neurology in Clinical Practice},
booktitle = {Bradley and Daroff's Neurology in
Clinical Practice},
abstract = {This chapter provides an overview on the diagnostic utility
of positron emission tomography (PET), single-photon
emission computed tomography (SPECT), and functional
magnetic resonance imaging (fMRI) in neurology. PET is now
providing essential imaging biomarkers for Alzheimer disease
(AD), especially for its early detection and differentiation
from other neurodegenerative diseases such as frontotemporal
dementia (FTD) and dementia with Lewy bodies (DLB). PET and
SPECT also play important roles for the diagnosis of
Parkinson disease, focal epilepsy, paraneoplastic
encephalitis, and coma. PET can demonstrate metabolic
activity of brain tumors and contribute to therapy planning
and early detection of recurrent tumors. Increasingly, fMRI,
which is still primarily a tool for research, may also
support diagnosis of neurodegenerative diseases, focal
epilepsy, and recovery after ischemic stroke. fMRI is also
used for the presurgical localization of motor and language
function.},
cin = {AG Teipel},
cid = {I:(DE-2719)1510100},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)7},
url = {https://pub.dzne.de/record/280934},
}